Abstract
GEN EdgeVol. 3, No. 1 CompaniesBrain Wave: Neumora Aims Precision Medicine at Neuro Diseases with $500M Launch, Amgen AllianceBiotech giant invests in startup emerging from stealth mode, focused on targeted therapies for neuropsychiatric and neurodegenerative disordersAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:2 Nov 2021https://doi.org/10.1089/genedge.3.1.108AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 3Issue 1Jan 2021 Information© 2021 by GEN PublishingTo cite this article:Alex Philippidis.Brain Wave: Neumora Aims Precision Medicine at Neuro Diseases with $500M Launch, Amgen Alliance.GEN Edge.Jan 2021.646-652.http://doi.org/10.1089/genedge.3.1.108Published in Volume: 3 Issue 1: November 2, 2021PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
